There is currently no approved
adjuvant treatment option available for patients with non-metastatic RCC at high risk for recurrence in the EU.
The FDA-approved use of the Perjeta-based regimen for
adjuvant treatment of HER2-positive eBC at high risk of recurrence is based on results of the Phase III APHINITY study.
3],[4] Additionally, it is difficult to predict patient prognosis and outcome, and there is a lack of
adjuvant treatment options for postsurgical HCC.
Comparison was then made between those who received the
adjuvant treatment options of intravesical BCG, mitomycin-C, or BCG and mitomycin versus those who received no
adjuvant treatment.
Patients with stage 3 disease without
adjuvant treatment had significantly more comorbidity according to the Charlson index (p < 0.
3] However,
adjuvant treatment failed to predict long-term survival in our research.
She did not receive any
adjuvant treatment at that time, and staging information is also not available for review.
To characterize the impact of the Oncotype DX test on
adjuvant treatment recommendations in stage II colon cancer, U.
However, there are no current studies evaluating the outcome of consistently performed radical excision without
adjuvant treatment for feline ISS.
Along with more surgery, the emotional and financial costs, delays in
adjuvant treatment, and poorer cosmetic outcomes associated with reoperation all add to stress levels in patients.
Aromasin is a prescription medicine for the
adjuvant treatment of postmenopausal women with estrogen receptor positive early breast cancer.
This is exciting because it means that a medication already used to treat other diseases may be efficient in the
adjuvant treatment of breast cancer as well," said lead researcher Juergen Veeck, from Maastricht University Medical Centre in The Netherlands.
